These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 21714120)

  • 21. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
    Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
    Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
    Wu PK; Chen WM; Chen CF; Lee OK; Haung CK; Chen TH
    Jpn J Clin Oncol; 2009 Aug; 39(8):514-22. PubMed ID: 19525290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas].
    Kimura H; Suzuki M; Ando S; Iida T; Iwata T; Tatesaki S; Isii T; Yonemoto T
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1319-23. PubMed ID: 15446550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
    Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
    Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of Danish cancer patients 1943-1987. Eye, brain and nervous system, thyroid, bone and connective tissue.
    Frisch M; Olsen JH
    APMIS Suppl; 1993; 33():156-82. PubMed ID: 8512738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intra-abdominal metastases from soft tissue sarcoma.
    Behranwala KA; Roy P; Giblin V; A'hern R; Fisher C; Thomas JM
    J Surg Oncol; 2004 Sep; 87(3):116-20. PubMed ID: 15334637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple primary soft tissue sarcomas.
    Grobmyer SR; Luther N; Antonescu CR; Singer S; Brennan MF
    Cancer; 2004 Dec; 101(11):2633-5. PubMed ID: 15494976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early lymphatic spread of osteogenic and soft-tissue sarcomas.
    Weingrad DN; Rosenberg SA
    Surgery; 1978 Aug; 84(2):231-40. PubMed ID: 278229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
    King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
    Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A proposed explanation for female predominance in alveolar soft part sarcoma. Noninactivation of X; autosome translocation fusion gene?
    Bu X; Bernstein L
    Cancer; 2005 Mar; 103(6):1245-53. PubMed ID: 15693033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain Metastasis in Soft Tissue Sarcoma at Initial Presentation.
    Itoga R; Matsuoka M; Onodera T; Yokota I; Iwasaki K; Matsubara S; Hishimura R; Suzuki Y; Iwata A; Kondo E; Iwasaki N
    Anticancer Res; 2021 Nov; 41(11):5611-5616. PubMed ID: 34732433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for patients with sarcomas of the pelvic bones.
    Kawai A; Healey JH; Boland PJ; Lin PP; Huvos AG; Meyers PA
    Cancer; 1998 Mar; 82(5):851-9. PubMed ID: 9486573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcoma Brain Metastases: 28 Years of Experience at a Single Institution.
    Al Sannaa G; Watson KL; Olar A; Wang WL; Fuller GN; McCutcheon I; Torres KE; Lazar AJ
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):962-967. PubMed ID: 27646022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soft-tissue sarcoma involving bone or neurovascular structures: MR imaging prognostic factors.
    Panicek DM; Go SD; Healey JH; Leung DH; Brennan MF; Lewis JJ
    Radiology; 1997 Dec; 205(3):871-5. PubMed ID: 9393550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis.
    Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
    J Surg Oncol; 2011 Dec; 104(7):771-5. PubMed ID: 21744348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical treatment of brain metastases from sarcoma].
    Wroński M
    Chir Narzadow Ruchu Ortop Pol; 1995; 60(1):55-60. PubMed ID: 7736836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The benefit of pulmonary metastectomy for bone and soft tissue sarcomas.
    Horan TA; Santiago FF; Araujo LM
    Int Surg; 2000; 85(3):185-9. PubMed ID: 11324992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
    Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
    Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors of bone and soft tissue sarcomas].
    Furuse K
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2050-5. PubMed ID: 3293534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.